» Articles » PMID: 25102124

Z-Selective Olefin Metathesis on Peptides: Investigation of Side-chain Influence, Preorganization, and Guidelines in Substrate Selection

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2014 Aug 8
PMID 25102124
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Olefin metathesis has emerged as a promising strategy for modulating the stability and activity of biologically relevant compounds; however, the ability to control olefin geometry in the product remains a challenge. Recent advances in the design of cyclometalated ruthenium catalysts has led to new strategies for achieving such control with high fidelity and Z selectivity, but the scope and limitations of these catalysts on substrates bearing multiple functionalities, including peptides, remained unexplored. Herein, we report an assessment of various factors that contribute to both productive and nonproductive Z-selective metathesis on peptides. The influence of sterics, side-chain identity, and preorganization through peptide secondary structure are explored by homodimerization, cross metathesis, and ring-closing metathesis. Our results indicate that the amino acid side chain and identity of the olefin profoundly influence the activity of cyclometalated ruthenium catalysts in Z-selective metathesis. The criteria set forth for achieving high conversion and Z selectivity are highlighted by cross metathesis and ring-closing metathesis on diverse peptide substrates. The principles outlined in this report are important not only for expanding the scope of Z-selective olefin metathesis to peptides but also for applying stereoselective olefin metathesis in general synthetic endeavors.

Citing Articles

Triazole-modified Ru-carbene complexes: A valid olefin metathesis pre-catalyst for dynamic covalent chemistry via C=C bond formation.

Wang C, Zhang S, Yuan T, Jimoh A, Abreu M, Shan C Chem Catal. 2023; 3(8).

PMID: 37873035 PMC: 10588561. DOI: 10.1016/j.checat.2023.100678.


Catalysis with cycloruthenated complexes.

Findlay M, Domingo-Legarda P, McArthur G, Yen A, Larrosa I Chem Sci. 2022; 13(12):3335-3362.

PMID: 35432864 PMC: 8943884. DOI: 10.1039/d1sc06355c.


Macrocyclization strategies for cyclic peptides and peptidomimetics.

Bechtler C, Lamers C RSC Med Chem. 2021; 12(8):1325-1351.

PMID: 34447937 PMC: 8372203. DOI: 10.1039/d1md00083g.


Solid-Phase Peptide Macrocyclization and Multifunctionalization via Dipyrrin Construction.

Wu Y, Chau H, Thor W, Chan K, Ma X, Chan W Angew Chem Int Ed Engl. 2021; 60(37):20301-20307.

PMID: 34272794 PMC: 8457249. DOI: 10.1002/anie.202108885.


Peptidomimetics prepared by tail-to-side chain one component peptide stapling inhibit Alzheimer's amyloid-β fibrillogenesis.

Kalita S, Kalita S, Paul A, Sarkar A, Mandal B Chem Sci. 2021; 11(16):4171-4179.

PMID: 34122880 PMC: 8152599. DOI: 10.1039/c9sc06076f.


References
1.
Guo Z, Mohanty U, Noehre J, Sawyer T, Sherman W, Krilov G . Probing the alpha-helical structural stability of stapled p53 peptides: molecular dynamics simulations and analysis. Chem Biol Drug Des. 2010; 75(4):348-59. DOI: 10.1111/j.1747-0285.2010.00951.x. View

2.
Chatterjee A, Choi T, Sanders D, Grubbs R . A general model for selectivity in olefin cross metathesis. J Am Chem Soc. 2005; 125(37):11360-70. DOI: 10.1021/ja0214882. View

3.
Karran E, Mercken M, De Strooper B . The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011; 10(9):698-712. DOI: 10.1038/nrd3505. View

4.
Tatton M, Simpson I, Donohoe T . De novo synthesis of multisubstituted aryl amines using alkene cross metathesis. Org Lett. 2014; 16(7):1920-3. PMC: 3979090. DOI: 10.1021/ol500441q. View

5.
Phillips C, Roberts L, Schade M, Bazin R, Bent A, Davies N . Design and structure of stapled peptides binding to estrogen receptors. J Am Chem Soc. 2011; 133(25):9696-9. DOI: 10.1021/ja202946k. View